Early Confirmed Keynotes for TIDES 2023
Each year, the TIDES conference scientific agenda includes 150+ of the industry's top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products.
Get the latest event updates
ACCESS NOVEL SCIENCE ACROSS THE ENTIRE OLIGONUCLEOTIDE, PEPTIDE, AND MRNA SPECTRUM
Cross-fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas.
The TIDES USA program features concurrent tracks covering the following 6 scientific themes including in-depth development strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing. Your registration provides access to the presentations across all 4 tracks, allowing you to create your own customized agenda.
Oligonucleotide Chemistry, Manufacturing & Controls
Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.
Oligonucleotide Discovery, Preclinical and Clinical
Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.
Peptide Chemistry, Manufacturing & Controls
Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.
Peptide Discovery, Preclinical and Clinical
Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.
mRNA Therapeutics/Vaccines & Genome Editing
Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies, and learn about state-of-the-art technologies for genome editing applications and hear about progress in genome editing delivery
Drug Delivery Innovations
Explore new technologies and approaches in the delivery of macromolecular therapeutics featuring multiple case studies of the delivery of oligonucleotides, peptides, mRNA therapeutics and genome editing delivery strategies. Learn about cutting-edge delivery advances including targeted delivery approaches for oligonucleotides, device-based delivery strategies and oral delivery of peptides.
CONNECT WITH THE INDUSTRY ANYWHERE IN THE WORLD
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals. Our 2023 hybrid event will offer you the most flexibility needed during these uncertain times.
For more information, click the link below or email Mike Dunnet directly at email@example.com.
Jesper Lau, Ph.D.
VP, Protein and Peptide Chemistry
Novo Nordisk, Denmark
The yearly TIDES conferences are among the most important events within peptide and oligonucleotide discovery and development and it has always been among my high priority to be able to join them. I am thus delighted to learn that Informa Connect will deliver TIDES USA Boston 2020 in a virtual format, and I am convinced that a digital meeting will be extremely appreciated in order to continue the important global communication among the scientific communities during these tough times.